135 related articles for article (PubMed ID: 32014921)
1. Tumor Suppression in Asymptomatic Postmenopausal Endometrial Polyps.
Adomaitiene L; Nadisauskiene R; Nickkho-Amiry M; Cizauskas A; Palubinskiene J; Holland C; Seif MW
Anticancer Res; 2020 Feb; 40(2):789-794. PubMed ID: 32014921
[TBL] [Abstract][Full Text] [Related]
2. Proliferation in Postmenopausal Endometrial Polyps-A Potential for Malignant Transformation.
Adomaitienė L; Nadišauskienė R; Nickkho-Amiry M; Čižauskas A; Palubinskienė J; Holland C; Seif MW
Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31466367
[No Abstract] [Full Text] [Related]
3. Expression of p53, Ki-67, and CD31 proteins in endometrial polyps of postmenopausal women treated with tamoxifen.
Miranda SP; Traiman P; Cândido EB; Lages EL; Freitas GF; Lamaita RM; Vidigal PV; da Silva Filho AL
Int J Gynecol Cancer; 2010 Dec; 20(9):1525-30. PubMed ID: 21119367
[TBL] [Abstract][Full Text] [Related]
4. Is there a survival advantage in diagnosing endometrial cancer in asymptomatic postmenopausal patients? An Israeli Gynecology Oncology Group study.
Gemer O; Segev Y; Helpman L; Hag-Yahia N; Eitan R; Raban O; Vaknin Z; Leytes S; Ben Arie A; Amit A; Levy T; Namazov A; Volodarsky M; Ben Shachar I; Atlas I; Bruchim I; Lavie O
Am J Obstet Gynecol; 2018 Aug; 219(2):181.e1-181.e6. PubMed ID: 29792852
[TBL] [Abstract][Full Text] [Related]
5. The utility of endometrial thickness measurement in asymptomatic postmenopausal women with endometrial fluid.
Seckin B; Ozgu-Erdinc AS; Dogan M; Turker M; Cicek MN
J Obstet Gynaecol; 2016; 36(2):230-3. PubMed ID: 26467302
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the diagnostic role of transvaginal ultrasound measurements of endometrial thickness to detect endometrial malignancy in asymptomatic postmenopausal women.
Yasa C; Dural O; Bastu E; Ugurlucan FG; Nehir A; İyibozkurt AC
Arch Gynecol Obstet; 2016 Aug; 294(2):311-6. PubMed ID: 26946152
[TBL] [Abstract][Full Text] [Related]
7. Is the immunohistochemical expression of proliferation (Ki-67) and apoptosis (Bcl-2) markers and cyclooxigenase-2 (COX-2) related to carcinogenesis in postmenopausal endometrial polyps?
Antunes A; Andrade LA; Pinto GA; Leão R; Pinto-Neto AM; Costa-Paiva L
Anal Quant Cytopathol Histpathol; 2012 Oct; 34(5):264-72. PubMed ID: 23301386
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of malignancy in endometrial polyps during postmenopause.
Mossa B; Torcia F; Avenoso F; Tucci S; Marziani R
Eur J Gynaecol Oncol; 2010; 31(2):165-8. PubMed ID: 20527232
[TBL] [Abstract][Full Text] [Related]
10. The significance of intrauterine lesions detected by ultrasound in asymptomatic postmenopausal patients.
Lev-Sagie A; Hamani Y; Imbar T; Hurwitz A; Lavy Y
BJOG; 2005 Mar; 112(3):379-81. PubMed ID: 15713160
[TBL] [Abstract][Full Text] [Related]
11. Association of ovarian hyperthecosis with endometrial polyp, endometrial hyperplasia, and endometrioid adenocarcinoma in postmenopausal women: a clinicopathological study of 238 cases.
Zhang C; Sung CJ; Quddus MR; Simon RA; Jazaerly T; Lawrence WD
Hum Pathol; 2017 Jan; 59():120-124. PubMed ID: 27746268
[TBL] [Abstract][Full Text] [Related]
12. Predictors of malignancy in endometrial polyps: study of 421 women with postmenopausal bleeding.
Ghoubara A; Sundar S; Ewies AAA
Climacteric; 2018 Feb; 21(1):82-87. PubMed ID: 29219004
[TBL] [Abstract][Full Text] [Related]
13. Risk and predictors of malignancy in women with endometrial polyps.
Wethington SL; Herzog TJ; Burke WM; Sun X; Lerner JP; Lewin SN; Wright JD
Ann Surg Oncol; 2011 Dec; 18(13):3819-23. PubMed ID: 21701931
[TBL] [Abstract][Full Text] [Related]
14. How often are endometrial polyps malignant in asymptomatic postmenopausal women? A multicenter study.
Ferrazzi E; Zupi E; Leone FP; Savelli L; Omodei U; Moscarini M; Barbieri M; Cammareri G; Capobianco G; Cicinelli E; Coccia ME; Donarini G; Fiore S; Litta P; Sideri M; Solima E; Spazzini D; Testa AC; Vignali M
Am J Obstet Gynecol; 2009 Mar; 200(3):235.e1-6. PubMed ID: 19027096
[TBL] [Abstract][Full Text] [Related]
15. [Clinical characteristics of 42 cases of malignant endometrial polyps].
Tang Z; Zhou R; Bao D; Liu C; Wei L
Zhonghua Fu Chan Ke Za Zhi; 2014 Mar; 49(3):204-7. PubMed ID: 24820306
[TBL] [Abstract][Full Text] [Related]
16. Endometrial polyps in pre- and postmenopausal women: factors associated with malignancy.
Antunes A; Costa-Paiva L; Arthuso M; Costa JV; Pinto-Neto AM
Maturitas; 2007 Aug; 57(4):415-21. PubMed ID: 17587515
[TBL] [Abstract][Full Text] [Related]
17. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.
Giordano G; Gnetti L; Merisio C; Melpignano M
Maturitas; 2007 Feb; 56(2):190-7. PubMed ID: 16963204
[TBL] [Abstract][Full Text] [Related]
18. Expression of cyclooxygenase-2, matrix metalloproteinase-2 and matrix metalloproteinase-9 in premenopausal and postmenopausal endometrial polyps.
Erdemoglu E; Güney M; Karahan N; Mungan T
Maturitas; 2008 Mar; 59(3):268-74. PubMed ID: 18378414
[TBL] [Abstract][Full Text] [Related]
19. Risk of malignancy in endometrial polyps in premenopausal and postmenopausal women according to clinicopathologic characteristics.
Costa-Paiva L; Godoy CE; Antunes A; Caseiro JD; Arthuso M; Pinto-Neto AM
Menopause; 2011 Dec; 18(12):1278-82. PubMed ID: 21926931
[TBL] [Abstract][Full Text] [Related]
20. Role of endometrial sampling in cases with asymptomatic cervical polyps.
Budak A; Kanmaz AG
J Gynecol Obstet Hum Reprod; 2019 Mar; 48(3):207-211. PubMed ID: 30660657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
